2024
Systemic anti-cancer treatment and healthcare utilization at end of life: A SEER Medicare analysis.
Adelson K, Canavan M, Niu J, Zhao H, Nortje N, Xiang J, Giordano S, Cheng L. Systemic anti-cancer treatment and healthcare utilization at end of life: A SEER Medicare analysis. Journal Of Clinical Oncology 2024, 20: 276-276. DOI: 10.1200/op.2024.20.10_suppl.276.Peer-Reviewed Original ResearchEnd-of-lifeSystemic anticancer therapyDay of deathIntensive care unit useIntensive care unitHealthcare utilizationEmergency departmentCombined chemo-immunotherapyEnd-of-life chemotherapy useAssociated with healthcare utilizationImmunotherapy useChemo-ImmunotherapyIncreased healthcare useEnd of lifeAdverse quality of lifeAssociated with higher EDCare unitQuality of lifeSystemic anti-cancer treatmentHospice useDay hospiceHospice enrollmentSEER-Medicare databaseUse of chemotherapyHealthcare useTrends in use of intensive care during hospitalizations at the end‐of‐life among older adults with advanced cancer
Jain S, Long J, Rao V, Law A, Walkey A, Prsic E, Lindenauer P, Krumholz H, Gross C. Trends in use of intensive care during hospitalizations at the end‐of‐life among older adults with advanced cancer. Journal Of The American Geriatrics Society 2024, 72: 3840-3848. PMID: 39090970, PMCID: PMC11637920, DOI: 10.1111/jgs.19119.Peer-Reviewed Original ResearchEnd-of-life hospitalizationsLife-sustaining treatmentEnd-of-lifeIntensity of careIn-Hospital DeathOlder adultsIntensive care unitAdvanced cancerRisk-adjusted hospitalEvaluate trendsIncreased intensity of careIntensive care unit useSEER-Medicare dataIntensive care unit careMultinomial regression modelsYear of diagnosisIntensive careHospital categoryMedicare beneficiariesSEER-MedicareHospitalization ratesCareCancer characteristicsNoninvasive ventilationHospital
2023
Association of palliative care and hospital outcomes among solid tumour oncology inpatients
Im J, Chow R, Novosel M, Xiang J, Strait M, Rao V, Kapo J, Zimmermann C, Prsic E. Association of palliative care and hospital outcomes among solid tumour oncology inpatients. BMJ Supportive & Palliative Care 2023, 14: e1349-e1353. PMID: 36849221, DOI: 10.1136/spcare-2023-004207.Peer-Reviewed Original ResearchPalliative care consultationInpatient palliative care consultationCare consultationsHospital deathHospital outcomesICU admissionPalliative careIntensive care unit useRetrospective chart reviewSite of malignancyEmergency department visitsHospital outcome dataMultivariable logistic regressionLength of stayOncology admissionsChart reviewED visitsOncology inpatientsDepartment visitsMultivariable analysisICU levelMedical recordsPatient presentationRothman IndexHigher odds
2017
Trends in Hospital Utilization and Costs among Pediatric Palliative Care Recipients
Ananth P, Melvin P, Berry JG, Wolfe J. Trends in Hospital Utilization and Costs among Pediatric Palliative Care Recipients. Journal Of Palliative Medicine 2017, 20: 946-953. PMID: 28453361, DOI: 10.1089/jpm.2016.0496.Peer-Reviewed Original ResearchConceptsPediatric palliative carePPC consultationED visitsHospital admissionHospital costsHospital utilizationAnnual hospital admission rateIntensive care unit usePalliative care recipientsPercent of patientsRetrospective cohort studyAnnual ED visitsEmergency department visitsHospital admission ratesQuaternary children's hospitalYears of agePPC involvementCohort studyDepartment visitsMedian ageED useSingle centerChildren's HospitalPalliative careIll children
2015
Quality of End-of-Life Care for the Myelodysplastic Syndromes: Findings from a Large National Database
Fletcher S, Cronin A, Zeidan A, Odejide O, Gore S, Davidoff A, Steensma D, Abel G. Quality of End-of-Life Care for the Myelodysplastic Syndromes: Findings from a Large National Database. Blood 2015, 126: 3287. DOI: 10.1182/blood.v126.23.3287.3287.Peer-Reviewed Original ResearchDays of lifeMyelodysplastic syndromeICU admissionLife careSolid tumorsTransfusion-dependent MDS patientsIntensive care unit useBlood cancersMultivariable logistic regression modelBlood pressure supportQuality of EOLMarital statusTransfusion-dependent patientsSpecific hematologic malignanciesQuality of endLarge national databaseYears of ageOdds of enrollmentLogistic regression modelsBone marrow failurePalliative needsHospice enrollmentSurveillance EpidemiologyTransfusion dependenceMDS patientsResource Use in the Last Year of Life Among Patients Who Died With Versus of Prostate Cancer
Dinan MA, Li Y, Zhang Y, Stewart SB, Curtis LH, George DJ, Reed SD. Resource Use in the Last Year of Life Among Patients Who Died With Versus of Prostate Cancer. Clinical Genitourinary Cancer 2015, 14: 28-37.e2. PMID: 26382223, PMCID: PMC4698191, DOI: 10.1016/j.clgc.2015.07.006.Peer-Reviewed Original ResearchConceptsEnd Results-Medicare dataEnd of lifeProstate cancerOutpatient settingOutpatient useRetrospective analysisMore hospicesLower mean inpatient costsSkilled nursing facility daysIntensive care unit daysIntensive care unit useJudicious careAndrogen deprivation therapyOverall health care costsUse of chemotherapyMean inpatient costsMultiple invasive proceduresHealth care costsSignificant financial burdenDeprivation therapyNoncancer causesICU useSingle strongest predictorUnit daysInpatient costs
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply